Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Xinyaqiang Silicon Chemistry Co.,Ltd (603155.SS)
Suqian, CN
Headquartered in Suqian, China, Xinyaqiang Silicon Chemistry Co.,Ltd, founded in 2009, specializes in the production and distribution of organic silicon compounds, specifically methylsilane and phenyl derivatives. Their diverse product portfolio encompasses chemicals such as hexamethyldisiloxane, iodotrimethylsilane, chlorotrimethylsilane, hexamethyldisilane, diethoxydimethylsilane, dimethoxydimethylsilane, phenyltrichlorosilane, dichlorodiphenylsilane, dichlorodimethylsilane, trimethylethoxysilane, methyltrimethoxysilane, and methyltriethoxysilane. Additionally, they provide specialty silazanes and siloxanes, including 1,3-divinyltetramethyldisilazane, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane, N,1,1,1-tetramethyl-N-(trimethylsilyl)silylamine, 1,1,1,3,3,3-hexamethyldisilazane, and 1,3-Bis(trimethylsilyl)urea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.32% | -10.03% | +0.96% | -12.93% | -8.32% | +4.20% | +30.39% | -5.25% | -24.46% | -20.98% | -20.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-18.2% Q1'26: +18.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-27.8% Q1'26: +22.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-2.4% Q1'26: -0.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.2% ★ Q1'26: +15.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.3% ★ Q1'26: +11.2% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.6% ★ Q1'26: -7.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.47× ★ Q1'26: 0.06× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|
| Revenue |
490.33M
est: 498.00M (-1.5%)
|
880.00M
est: 853.29M (+3.1%)
|
1.13B
est: 1.55B (-26.9%)
|
675.20M
est: 2.41B (-72.0%)
|
720.54M
est: 2.60B (-72.3%)
|
| EBITDA |
206.73M
est: 173.15M (+19.4%)
|
394.37M
est: 296.68M (+32.9%)
|
385.01M
est: 539.46M (-28.6%)
|
189.15M
est: 838.77M (-77.4%)
|
179.49M
est: 762.37M (-76.5%)
|
| EBIT |
182.92M
est: 148.56M (+23.1%)
|
369.54M
est: 254.55M (+45.2%)
|
346.90M
est: 462.86M (-25.1%)
|
142.14M
est: 719.67M (-80.2%)
|
131.54M
est: 619.82M (-78.8%)
|
| Net Income |
157.34M
est: 169.01M (-6.9%)
|
319.44M
est: 283.24M (+12.8%)
|
301.72M
est: 422.04M (-28.5%)
|
123.44M
est: 589.95M (-79.1%)
|
114.36M
est: 676.69M (-83.1%)
|
| SGA |
22.50M
est: 4.14M (+443.9%)
|
19.79M
est: 7.09M (+179.1%)
|
21.12M
est: 12.89M (+63.8%)
|
22.95M
est: 20.04M (+14.5%)
|
21.22M
est: 71.35M (-70.3%)
|
| EPS |
0.60
est: 0.53 (+12.8%)
|
1.01
est: 0.89 (+13.3%)
|
0.96
est: 1.33 (-27.7%)
|
0.39
est: 1.86 (-79.0%)
|
0.36
est: 2.14 (-83.2%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chunshan Liu | Deputy General Manager | — | male |
| Na Song | Financial Director | — | female |
| Shijuan Liu | Accounting Supervisor | — | — |
| Xiushen Sang | Deputy GM & Board Secretary | — | male |
| Yining Pan | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603155.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
